Cargando…

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy

OBJECTIVE: To investigate the effect of benfotiamine on urinary albumin excretion (UAE) and the tubular damage marker kidney injury molecule-1 (KIM-1) in patients with type 2 diabetes and nephropathy. RESEARCH DESIGN AND METHODS: Patients with type 2 diabetes and UAE equivalent to 15–300 mg/24 h, de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkhalaf, Alaa, Klooster, Astrid, van Oeveren, Willem, Achenbach, Ulrike, Kleefstra, Nanne, Slingerland, Robbert J., Mijnhout, G. Sophie, Bilo, Henk J.G., Gans, Reinold O.B., Navis, Gerjan J., Bakker, Stephan J.L.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890365/ https://www.ncbi.nlm.nih.gov/pubmed/20413516 http://dx.doi.org/10.2337/dc09-2241

Ejemplares similares

Effect of Benfotiamine on Advanced Glycation Endproducts and Markers of Endothelial Dysfunction and Inflammation in Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2012)

Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials
por: Mijnhout, Gerritje S., et al.
Publicado: (2012)

Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31)
por: Riphagen, Ineke J., et al.
Publicado: (2013)

Plasma COOH-Terminal Proendothelin-1: A marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29)
por: Drion, Iefke, et al.
Publicado: (2012)

Self-Monitoring of Blood Glucose: The Use of the First or the Second Drop of Blood
por: Hortensius, Johanna, et al.
Publicado: (2011)

Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2010)

Serum Peroxiredoxin 4: A Marker of Oxidative Stress Associated with Mortality in Type 2 Diabetes (ZODIAC-28)
por: Gerrits, Esther G., et al.
Publicado: (2014)

Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
por: Landman, Gijs W.D., et al.
Publicado: (2010)

Health-Related Quality of Life and Mortality in a General and Elderly Population of Patients With Type 2 Diabetes (ZODIAC-18)
por: Landman, Gijs W.D., et al.
Publicado: (2010)

Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up
por: van Dijk, Peter R, et al.
Publicado: (2014)

Comparison of Methods for Renal Risk Prediction in Patients with Type 2 Diabetes (ZODIAC-36)
por: Riphagen, Ineke J., et al.
Publicado: (2015)

Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
por: Kleefstra, Nanne, et al.
Publicado: (2009)

Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2009)

Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887–2894
por: Kleefstra, Nanne, et al.
Publicado: (2013)

The Midregional Fragment of Pro-A–Type Natriuretic Peptide, Blood Pressure, and Mortality in a Prospective Cohort Study of Patients With Type 2 Diabetes (ZODIAC-25)
por: van Hateren, Kornelis J.J., et al.
Publicado: (2013)

Association Between CNDP1 Genotype and Diabetic Nephropathy Is Sex Specific
por: Mooyaart, Antien L., et al.
Publicado: (2010)

Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4)
por: Fokkert, Marion, et al.
Publicado: (2019)

Skin Autofluorescence: A Pronounced Marker of Mortality in Hemodialysis Patients
por: Gerrits, Esther G., et al.
Publicado: (2012)

Is guideline-adherent prescribing associated with quality of life in patients with type 2 diabetes?
por: Smits, Kirsten P. J., et al.
Publicado: (2018)

Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32)
por: van Hateren, Kornelis J. J., et al.
Publicado: (2015)

Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15)
por: Landman, Gijs WD, et al.
Publicado: (2012)

The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35)
por: van Dijk, Peter R, et al.
Publicado: (2015)

Pancreatic β-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation
por: Zelle, Dorien M., et al.
Publicado: (2013)

Optimising drug prescribing and dispensing in subjects at risk for drug errors due to renal impairment: improving drug safety in primary healthcare by low eGFR alerts
por: Joosten, Hanneke, et al.
Publicado: (2013)

Perspectives of patients with type 1 or insulin-treated type 2 diabetes on self-monitoring of blood glucose: a qualitative study
por: Hortensius, Johanna, et al.
Publicado: (2012)

Laser therapy for onychomycosis in patients with diabetes at risk for foot complications: study protocol for a randomized, double-blind, controlled trial (LASER-1)
por: Nijenhuis-Rosien, Leonie, et al.
Publicado: (2015)

Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)
por: Roelofsen, Yvonne, et al.
Publicado: (2014)

Muscle mass versus body mass index as predictor of adverse outcome
por: Groothof, Dion, et al.
Publicado: (2021)

Incidence of renal replacement therapy for diabetic nephropathy in the Netherlands: Dutch diabetes estimates (DUDE)-3
por: van Dijk, Peter R, et al.
Publicado: (2015)

Thiamine and benfotiamine: Focus on their therapeutic potential
por: Bozic, Iva, et al.
Publicado: (2023)

Increased Insulin Requirements During Exercise at Very High Altitude in Type 1 Diabetes
por: de Mol, Pieter, et al.
Publicado: (2011)

Glucose–insulin–potassium infusion in sepsis and septic shock: no hard evidence yet
por: van der Horst, Iwan CC, et al.
Publicado: (2003)

Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2010)

Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques
por: Drion, Iefke, et al.
Publicado: (2012)

Type 2 diabetes seems not to be a risk factor for the carpal tunnel syndrome: a case control study
por: Hendriks, Steven H, et al.
Publicado: (2014)

A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus
por: Alkhalaf, A., et al.
Publicado: (2010)

Preventive effects of benfotiamine in chronic diabetic complications
por: Chakrabarti, Rana, et al.
Publicado: (2011)

Prostatic Acid Phosphatase Is Required for the Antinociceptive Effects of Thiamine and Benfotiamine
por: Hurt, Julie K., et al.
Publicado: (2012)

Demographical, Clinical, and Psychological Characteristics of Users and Nonusers of an Online Platform for T2DM Patients (e-VitaDM-3/ZODIAC-44)
por: Roelofsen, Yvonne, et al.
Publicado: (2016)

Performance of the Eversense versus the Free Style Libre Flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus
por: Fokkert, Marion, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_69iqrcjs3g9f64plto9a7gvk65